Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis.

[1]  Szilvia Szép,et al.  The antioxidant role of thiocyanate in the pathogenesis of cystic fibrosis and other inflammation-related diseases , 2009, Proceedings of the National Academy of Sciences.

[2]  P. Sly,et al.  Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. , 2009, American journal of respiratory and critical care medicine.

[3]  A. Kettle,et al.  Hypobromous acid and bromamine production by neutrophils and modulation by superoxide. , 2009, The Biochemical journal.

[4]  V. Cameron,et al.  Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. , 2007, Journal of the American College of Cardiology.

[5]  S. Randell,et al.  The lactoperoxidase system links anion transport to host defense in cystic fibrosis , 2007, FEBS letters.

[6]  J. Zabner,et al.  A novel host defense system of airways is defective in cystic fibrosis. , 2007, American journal of respiratory and critical care medicine.

[7]  S. Kohlhoff,et al.  Serum myeloperoxidase in cystic fibrosis patients receiving systemic antibiotics , 2007, Scandinavian journal of infectious diseases.

[8]  M. Davies,et al.  Reactions of myeloperoxidase-derived oxidants with biological substrates: gaining chemical insight into human inflammatory diseases. , 2006, Current medicinal chemistry.

[9]  A. Kettle,et al.  Bromination and chlorination reactions of myeloperoxidase at physiological concentrations of bromide and chloride. , 2006, Archives of biochemistry and biophysics.

[10]  P. Bye,et al.  Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects. , 2005, American journal of respiratory and critical care medicine.

[11]  A. Kettle,et al.  Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis. , 2004, American journal of respiratory and critical care medicine.

[12]  Erik J. Saude,et al.  NMR analysis of neutrophil activation in sputum samples from patients with cystic fibrosis , 2004, Magnetic resonance in medicine.

[13]  C. Milla,et al.  Peroxidase activity within circulating neutrophils correlates with pulmonary phenotype in cystic fibrosis. , 2004, The Journal of laboratory and clinical medicine.

[14]  G. Conner,et al.  Lactoperoxidase and human airway host defense. , 2003, American journal of respiratory cell and molecular biology.

[15]  R. Hotchkiss,et al.  Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Linsdell.  Thiocyanate as a probe of the cystic fibrosis transmembrane conductance regulator chloride channel pore. , 2001, Canadian journal of physiology and pharmacology.

[17]  W. Parks,et al.  Bromination of deoxycytidine by eosinophil peroxidase: a mechanism for mutagenesis by oxidative damage of nucleotide precursors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Cross,et al.  Myeloperoxidase and protein oxidation in cystic fibrosis. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[19]  C. Obinger,et al.  The reactivity of myeloperoxidase compound I formed with hypochlorous acid , 2000, Redox report : communications in free radical research.

[20]  A. Clément,et al.  Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. , 2000 .

[21]  J. Kanga,et al.  Cystic fibrosis clinical score: a new scoring system to evaluate acute pulmonary exacerbation. , 1999, Clinical therapeutics.

[22]  C. Cross,et al.  Reactive nitrogen species and tyrosine nitration in the respiratory tract: epiphenomena or a pathobiologic mechanism of disease? , 1999, American journal of respiratory and critical care medicine.

[23]  S. Hazen,et al.  3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: potential markers for eosinophil-dependent tissue injury in vivo. , 1999, Biochemistry.

[24]  J. Heinecke.  Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. , 1998, Atherosclerosis.

[25]  P. Venge,et al.  Serum eosinophil cationic protein, eosinophil protein X and eosinophil peroxidase in relation to pulmonary function in cystic fibrosis , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[26]  A. Kettle,et al.  Thiocyanate and chloride as competing substrates for myeloperoxidase. , 1997, The Biochemical journal.

[27]  A. Kettle,et al.  Myeloperoxidase: a key regulator of neutrophil oxidant production. , 1997, Redox report : communications in free radical research.

[28]  C. Winterbourn,et al.  Protein carbonyl measurement by a sensitive ELISA method. , 1997, Free radical biology & medicine.

[29]  D. Koller,et al.  Relationship between disease severity and inflammatory markers in cystic fibrosis. , 1996, Archives of disease in childhood.

[30]  D. Riches,et al.  Early pulmonary inflammation in infants with cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.

[31]  W. Regelmann,et al.  Sputum peroxidase activity correlates with the severity of lung disease in cystic fibrosis , 1995, Pediatric pulmonology.

[32]  D. Koller,et al.  Eosinophilic activation in cystic fibrosis. , 1994, Thorax.

[33]  M. Jefferson,et al.  Leukocyte Myeloperoxidase and Salivary Lactoperoxidase: Identification and Quantitation in Human Mixed Saliva , 1994, Journal of dental research.

[34]  D. Learn,et al.  Inhibition of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase by dapsone. , 1992, Biochemical pharmacology.

[35]  D. Learn,et al.  Assay of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase. , 1990, Journal of immunological methods.

[36]  S. Weiss,et al.  Brominating oxidants generated by human eosinophils. , 1986, Science.

[37]  F. Moll.  Disc Electrophoresis and Related Techniques of Polyacrylamide Gel Electrophoresis. Von H.R. Maurer. XVI, 222 S., 88 Fig., 16 Tab. Walter de Gruyter, Berlin–New York 1971. Preis: DM 68,– , 1972 .

[38]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.

[39]  K. Agner,et al.  Studies on Myeloperoxidase Activity. I. Spectrophotometry of the MPO-H2O2 Compound. , 1963 .